NDC 36987-2075

Rhizopus oryzae

Rhizopus Oryzae

Rhizopus oryzae is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nelco Laboratories, Inc.. The primary component is Rhizopus Arrhizus Var. Arrhizus.

Product ID36987-2075_0dbb0652-e487-4678-a747-b379f75821dc
NDC36987-2075
Product TypeHuman Prescription Drug
Proprietary NameRhizopus oryzae
Generic NameRhizopus Oryzae
Dosage FormInjection, Solution
Route of AdministrationINTRADERMAL; SUBCUTANEOUS
Marketing Start Date1972-08-29
Marketing CategoryBLA / BLA
Application NumberBLA102192
Labeler NameNelco Laboratories, Inc.
Substance NameRHIZOPUS ARRHIZUS VAR. ARRHIZUS
Active Ingredient Strength20000 [PNU]/mL
Pharm ClassesNon-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 36987-2075-1

5 mL in 1 VIAL, MULTI-DOSE (36987-2075-1)
Marketing Start Date1972-08-29
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 36987-2075-2 [36987207502]

Rhizopus oryzae INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

NDC 36987-2075-3 [36987207503]

Rhizopus oryzae INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

NDC 36987-2075-1 [36987207501]

Rhizopus oryzae INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

NDC 36987-2075-4 [36987207504]

Rhizopus oryzae INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

Drug Details

Active Ingredients

IngredientStrength
RHIZOPUS ARRHIZUS VAR. ARRHIZUS20000 [PNU]/mL

OpenFDA Data

SPL SET ID:102d5d44-e217-4e5d-a9ac-a242388a5cc9
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 889579
  • 999456
  • 968484
  • 967953
  • 967904
  • 967543
  • 889538
  • 1000163
  • 999432
  • 999513
  • 999492
  • 968534
  • 999498
  • 968456
  • 968149
  • 999449
  • 966954
  • 999402
  • 999443
  • 999468
  • 999462
  • 1006335
  • 905079
  • 999425
  • 999427
  • 999393
  • 999503
  • 968400
  • 966689
  • 966666
  • 967045
  • 967057
  • 889611
  • Pharm Class PE
  • Cell-mediated Immunity [PE]
  • Increased IgG Production [PE]
  • Increased Histamine Release [PE]
  • PHarm Class EPC
  • Non-Standardized Fungal Allergenic Extract [EPC]
  • NUI Code
  • N0000185001
  • N0000175629
  • N0000171131
  • N0000185372
  • N0000169106
  • N0000184306
  • Pharmacological Class

    • Non-Standardized Fungal Allergenic Extract [EPC]
    • Increased Histamine Release [PE]
    • Cell-mediated Immunity [PE]
    • Increased IgG Production [PE]
    • Fungal Proteins [Chemical/Ingredient]
    • Allergens [Chemical/Ingredient]

    NDC Crossover Matching brand name "Rhizopus oryzae" or generic name "Rhizopus Oryzae"

    NDCBrand NameGeneric Name
    22840-2619Rhizopus oryzaeRhizopus oryzae
    22840-2620Rhizopus oryzaeRhizopus oryzae
    22840-2621Rhizopus oryzaeRhizopus oryzae
    22840-5633Rhizopus oryzaeRhizopus oryzae
    36987-2073Rhizopus oryzaeRhizopus oryzae
    36987-2074Rhizopus oryzaeRhizopus oryzae
    36987-2075Rhizopus oryzaeRhizopus oryzae
    36987-2076Rhizopus oryzaeRhizopus oryzae
    36987-2077Rhizopus oryzaeRhizopus oryzae
    36987-2078Rhizopus oryzaeRhizopus oryzae
    36987-2079Rhizopus oryzaeRhizopus oryzae
    36987-2080Rhizopus oryzaeRhizopus oryzae
    36987-2081Rhizopus oryzaeRhizopus oryzae
    49643-118RhizopusRhizopus oryzae

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.